The β-HPV Subtypes-Cornerstone of the Next-Generation Vaccine

JAMA Oncol. 2017 May 1;3(5):594-595. doi: 10.1001/jamaoncol.2016.3415.

Authors

Jad Chahoud¹, Alyssa G Rieber¹, Stephen K Tyring²

Affiliations

¹ The University of Texas MD Anderson Cancer Center, Houston.
² The University of Texas Health Science Center at Houston McGovern Medical School Houston.

PMID: 27893031
DOI: 10.1001/jamaoncol.2016.3415

No abstract available

MeSH terms

Betapapillomavirus / pathogenicity*
Cancer Vaccines / pharmacology*
Female
Health Care Costs
Humans
Male
Papillomavirus Infections / prevention & control
Papillomavirus Infections / virology*
Papillomavirus Vaccines / immunology
Papillomavirus Vaccines / pharmacology*
United States
Uterine Cervical Neoplasms / economics
Uterine Cervical Neoplasms / prevention & control
Uterine Cervical Neoplasms / virology
Vaccination / legislation & jurisprudence

Substances

Cancer Vaccines
Papillomavirus Vaccines